SFStefano Forli

Stefano Forli

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Stefano Forli has a total of 535 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    MolScrub: an open-source tool to generate conformers and protonate drug-like molecules

    by Joani Mato, Diogo Santos-Martins, Manuel Augusto Llanos, Stefano Forli

    We introduce MolScrub, an open-source Python-based tool to prepare drug-like molecules for structure-based simulations. MolScrub takes common molecular input specifications like SMILES, predicts the protonation states, and generates 3D structures. It is a high-throughput tool, having an average runtime of 0.3 to 0.5 seconds per molecule per CPU core. MolScrub returns as few protomers and conformers as reasonable to avoid feeding high-energy states to downstream simulations. Protonation state assignment includes both pKa prediction for acid-base pairs and tautomer enumeration. During 3D-coordinate generation, MolScrub enumerates 6-membered ring conformations to ensure that the final structure is close to a global minimum. These improved input geometries benefit docking programs that do not change the internal state of small rings. MolScrub was primarily developed to generate high-quality ligand structures to support docking-based virtual screenings but its modules (pKa prediction, tautomer enumeration, and ring geometry corrections) can be used and configured independently to support other applications.

  • Open Access

    MCSwell: Thermodynamic Characterization of Binding Site Hydration

    by Niccolo’ Bruciaferri, Diogo Santos-Martins, Matthew Holcomb, Manuel A. Llanos, Stefano Forli

    Water molecules in protein binding sites play a central role in ligand recognition by mediating stabilizing interactions and contributing desolvation penalties upon displacement. Reliable identification of hydration sites and quantification of their thermodynamic contributions remain challenging, as experimental water placement is often uncertain and direct experimental measurements of individual water free energies are not available. Molecular dynamics (MD) simulations are commonly used to characterize binding-site hydration, but their ability to sample buried or partially occluded sites is limited by kinetic barriers and substantial computational cost. In this work, we present MCSwell, a GPU-accelerated Grand Canonical Monte Carlo (GCMC) method for efficient sampling of water molecules in protein binding sites. By enabling rapid insertion and deletion moves, MCSwell provides robust identification of both exposed and buried hydration sites and estimates their thermodynamic favorability within a rigorous statistical mechanical framework. The method is highly configurable and accessible through a lightweight Python interface, facilitating integration into structure-based drug discovery workflows. We evaluate MCSwell across several protein systems by comparison with hydration patterns derived from MD simulations and with WaterKit, a previously reported MC-based approach. MCSwell achieves comparable accuracy while reducing computational cost from hours to minutes, enabling rapid and systematic hydration site analysis. These results demonstrate the utility of MCSwell as an efficient tool for modeling binding-site hydration in molecular design applications.

  • Open Access

    Author Correction: Posttranslational modifications remodel proteome-wide ligandability

    by Weichao Li, Qijia Wei, Manuel Llanos, Clara Gathmann, Paolo Governa, Tzu-Yuan Chiu, Jacob M. Wozniak, Appaso M. Jadhav, Matthew Holcomb, Jacob Cravatt, et al.


  • Open Access

    Genetic and pharmacological inactivation of peptidoglycan remodeling increases antibiotic susceptibility of vancomycin-resistant Enterococcus faecium

    by Kyong T. Fam, Pavan Kumar Chodisetti, Zifei Wang, Joshua A. Homer, Christopher J. Smedley, Seiya Kitamura, Benjamin Silva, Yijun Xiong, Althea Hansel-Harris, Matthew Holcomb, et al.

    Vancomycin-resistant Enterococcus faecium (VREfm) is a leading cause of healthcare-associated infections globally and demands new approaches for treatment. Here we show that genetic and pharmacological inactivation of a highly conserved NlpC/P60 peptidoglycan hydrolase, secreted antigen A (SagA), enhanced vancomycin susceptibility of VREfm ex vivo and in vivo. Notably, genetic deletion of sagA impaired VREfm peptidoglycan remodeling, growth and increased the activity of vancomycin. We then identified first-in-class covalent NlpC/P60 peptidoglycan hydrolase inhibitors and demonstrated that pharmacological inactivation of SagA activity also impaired peptidoglycan remodeling and increased the efficacy of vancomycin across genetically distinct VREfm clinical isolates. Our study reveals peptidoglycan hydrolases are druggable targets whose inactivation improves the efficacy of vancomycin against VREfm.


  • Open Access

    The SLC15A4–LAMTOR1 interaction licenses endolysosomal TLR-mediated mTOR signaling and inflammatory cytokine production

    by Tzu-Yuan Chiu, Peter Rory Hall, Daniel C. Lazar, Arthur S. Kim, Stefano Forli, Andrew B. Ward, John R. Teijaro, Christopher G. Parker

    Endolysosomal Toll-like receptors (TLRs) 7–9 are critical mediators of antimicrobial immunity, but their dysregulation drives pathogenic inflammation in autoimmune diseases such as systemic lupus erythematosus (SLE). The endolysosomal solute carrier SLC15A4 is essential for TLR7–9-mediated cytokine production and is strongly linked to SLE susceptibility, yet our understanding of the precise mechanisms by which it coordinates innate immune signaling remains incomplete. Here, we identify a direct interaction between SLC15A4 and LAMTOR1, a core scaffold subunit of the lysosomal Ragulator complex, and show that is required for coupling endolysosomal TLR activation to mTORC1 and downstream inflammatory responses. Structural modeling and site-directed mutagenesis suggest that the α1 helix of LAMTOR1 engages the substrate-binding pocket of SLC15A4, and disruption of this interface broadly suppresses TLR7–9-mediated cytokine production. Notably, this interaction regulates mTOR activation, IRF5/7 signaling, and downstream transcriptional responses through stimulus-dependent mechanisms. These findings define a previously uncharacterized SLC15A4–LAMTOR1 signaling interface that coordinates endolysosomal TLR–mTOR coupling and shapes downstream cytokine output. Significance Statement: Dysregulated activation of endolysosomal Toll-like receptors (TLRs) 7–9 drives pathogenic inflammatory cytokine responses that underlie autoimmune diseases such as systemic lupus erythematosus. Despite the established role of the endolysosomal transporter SLC15A4 in this process, how it coordinates downstream immune signaling has remained incompletely understood. We show that SLC15A4 directly interacts with LAMTOR1, a core component of the lysosomal Ragulator complex, and that this interaction is required to activate mTOR and engage IRF5/7-dependent inflammatory programs downstream of TLR7–9. Disrupting this interface suppresses type I interferon and cytokine production, identifying the SLC15A4–LAMTOR1 interaction as a central node in endolysosomal innate immune signaling and validating it as a compelling target for therapeutic intervention in interferon-driven autoimmune disease.


  • Open Access

    Posttranslational modifications remodel proteome-wide ligandability

    by Weichao Li, Qijia Wei, Manuel Llanos, Clara Gathmann, Paolo Governa, Tzu-Yuan Chiu, Jacob M. Wozniak, Appaso M. Jadhav, Matthew Holcomb, Jacob Cravatt, et al.

    Posttranslational modifications (PTMs) vastly expand the diversity of the human proteome, dynamically reshaping protein activity, interactions and localization in response to environmental, pharmacologic and disease-associated cues. However, their proteome-wide impact on small-molecule recognition—and, thus, druggability—remains largely unexplored. Here we present a chemical proteomic strategy to delineate how PTM states remodel protein ligandability in human cells. Using broad-spectrum photoaffinity probes, we identified more than 400 functionally diverse proteins whose ability to engage small molecules is impacted by phosphorylation or N-linked glycosylation status. Integrating binding site mapping with structural analyses reveals a diverse array of PTM-dependent pockets. Among these, we discovered that the phosphorylation status of common oncogenic KRAS mutants impacts the action of small molecules, including clinically approved inhibitors. These findings illuminate a previously underappreciated layer of proteome plasticity governed by PTMs and highlight opportunities to develop chemical probes that selectively target proteins in defined modification states. The alternative text for this image may have been generated using AI.


  • Open Access

    Pharmacological Inhibition of SLC33A1 Promotes Endoplasmic Reticulum Hyperoxidation and Induces Adaptive IRE1/XBP1s Signaling

    by Sergei Kutseikin, Maria Rafiq, Prerona Bora, Shanshan Liu, Rick A. Homan, Jeffrey T. Mindrebo, Matthew Holcomb, H. Michael Petrassi, Huang Qiu, Anastasiya Redkina, et al.

    SUMMARY: The endoplasmic reticulum (ER) transporter solute carrier family 33 member 1 (SLC33A1) has emerged as an attractive therapeutic target in etiologically diverse diseases, ranging from lung cancer to neurodegenerative disorders. Yet, no pharmacologic SLC33A1 modulators have been described. Here, we show that the small molecule IXA4, a highly selective activator of the adaptive IRE1/XBP1s signaling arm of the unfolded protein response (UPR), binds to SLC33A1 and inhibits its activity. Genetic depletion of SLC33A1 phenocopies the selective induction of IRE1/XBP1s signaling brought about by IXA4 treatment. Chemoproteomic analyses and cryo-electron microscopy show that IXA4 binds SLC33A1 within the central channel to inhibit transport of its substrate metabolite(s). Binding of IXA4 to SLC33A1 leads to the accumulation of oxidized glutathione within the ER, hyperoxidizing the ER lumen and inducing activation of adaptive IRE1/XBP1s signaling. Consistent with this function, we find that pharmacologic inhibition of SLC33A1 with IXA4 selectively reduces viability of KEAP1-deficient lung adenocarcinoma cells that have elevated levels of glutathione, mimicking the sensitivity of these cells to genetic deletion of SLC33A1. Our work demonstrates a new physiologic role of SLC33A1 in regulation of ER redox homeostasis and designates IXA4 as a pharmacologic inhibitor of SLC33A1 that can be used to evaluate the biological impact and therapeutic utility of SLC33A1 inhibition in homeostasis and in disease.


  • AlphaFold-RandomWalk and AlphaFold-Ensemble: Sampling Alternative Protein Conformations with Perturbed Versions of AlphaFold

    by Ishan Taneja, Manuel A. Llanos, Monica L. Fernández-Quintero, Johannes R. Loeffler, Matthew Holcomb, Andrew B. Ward, Stefano Forli

    The ability of proteins to adopt multiple conformations is fundamental to their biological function. With the advent of AlphaFold, machine learning (ML)-based methods have extended their capabilities to more broadly sample this intrinsic conformational diversity. However, the extent to which ML approaches can independently generate ensembles of diverse and biologically relevant conformations remains an open question. We sought to tackle this challenge by developing AlphaFold-RandomWalk (AF-RW) and AlphaFold-Ensemble (AF-Ensemble), novel ML-based methods to generate diverse protein conformations. As opposed to traditional approaches which rely on modifying the input multiple sequence alignment, AF-RW systematically adds noise to the weights of the model on a per-target basis, significantly increasing the conformational diversity of predicted models compared to conventional methods. AF-Ensemble takes the complementary approach fine-tuning an ensemble of models to produce diversity from a set of two-state systems. Additionally, both methods were incorporated into an automated, multistage computational pipeline that seeds unbiased molecular dynamics simulations from ML-generated conformations to efficiently sample alternative conformations. When evaluated on a diverse set of ten proteins, our pipeline provided useful, MD-guided hypotheses for determining biologically meaningful alternative conformations. Moreover, simulations seeded from diverse ML-generated conformations provided a reasonable approximation to the free energy landscape of two challenging protein targets, K-Ras and ribose-binding protein. Overall, our work highlights the potential of combining diverse conformations generated by perturbing the weights of AF with molecular dynamics simulations to efficiently probe protein conformational heterogeneity.


  • Top Cited Papers

    Meeko: Molecule Parametrization and Software Interoperability for Docking and Beyond

    by Diogo Santos-Martins, Yiran He, Jerome Eberhardt, Parnika Sharma, Niccolò Bruciaferri, Matthew Holcomb, Manuel A. Llanos, Althea Hansel-Harris, Allison Pearl Barkdull, Andreas Frank Tillack, et al.

    Molecule parametrization is an essential requirement to guarantee the accuracy of docking calculations. Parametrization includes a proper perception of chemical properties such as bonds, formal charges and protonation states. This includes large biological macromolecules, such as proteins and nucleic acids, and small molecules, such as ligands and cofactors. The structures of proteins and nucleic acids are challenging due to omission of several atoms from the structural model, and from the lack of connectivity and bond order information in the PDB and mmCIF file formats. For small molecules, the very large chemical diversity poses challenges for both validating correctness and providing accurate parameters. These challenges affect various modeling approaches like molecular docking and molecular dynamics. Moreover, several specialized methods (particularly in molecular docking) leverage specific chemical properties to add custom potentials, pseudoatoms, or manipulate atomic connectivity. To address these challenges, we developed Meeko, a molecular parametrization Python package that leverages the widely used RDKit cheminformatics library for a chemically accurate description of the molecular representation. Small molecules are modeled as single RDKit molecules, and biological macromolecules as multiple RDKit molecules, one for each residue. Meeko is highly customizable and designed to be easily scriptable for high-throughput processing, replacing MGLTools for receptor and ligand preparation.


  • Open Access

    Architecting Tensor Core-Based Reductions for Irregular Molecular Docking Kernels

    by Leonardo Solis-Vasquez, Andreas F. Tillack, Diogo Santos-Martins, Andreas Koch, Stefano Forli